LMO2 and acute myeloid leukemia: ChIP-on-chip analysis for H3K9 acetylation in these cells (Figures 5a and b) revealed a pattern that was remarkably similar to that previously observed in AML patients, with strong enrichment at the Lmo2 +1 enhancer region (Figure 5a).